Literature DB >> 10425603

Conformational variety for the ansa chain of rifamycins: comparison of observed crystal structures and molecular dynamics simulations.

A Bacchi1, G Pelizzi.   

Abstract

The antibiotic activity (via inhibition of DNA-dependent RNA polymerase, DDRP) of rifamycins has been correlated to the conformation of the ansa chain, which can be described by means of 17 torsion angles defined along the ansa backbone. It has been shown that favourable or unfavourable conformations of the ansa chain in rifamycin crystals are generally diagnostic of activity or inactivity against isolated DDRP. The principles of structure correlation suggest that the torsional variety observed in rifamycin crystals should mimic the dynamic flexibility of the ansa chain in solution. Twenty-six crystal structures of rifamycins are grouped into two classes (active and non-active). For each class the variance of the 17 ansa backbone torsion angles is analysed. Active compounds show a well-defined common pattern, while non-active molecules are more scattered, mainly due to steric constraints forcing the molecules into unfavourable conformations. The experimental distributions of torsion angles are compared to the torsional freedom of the ansa chain simulated by molecular dynamics calculations performed at different temperatures and conditions on rifamycin S and rifamycin O, which represent a typical active and a typical sterically constrained molecule, respectively. It is shown that the torsional variety found in the crystalline state samples the dynamic behaviour of the ansa chain for active compounds. The methods of circular statistics are illustrated to describe torsion angle distributions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425603     DOI: 10.1023/a:1008070316079

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  10 in total

1.  Molecular structure and conformation of rifamycin S, a potent inhibitor of DNA-dependent RNA polymerase.

Authors:  S K Arora; P Arjunan
Journal:  J Antibiot (Tokyo)       Date:  1992-03       Impact factor: 2.649

2.  Rifamycins: an insight into biological activity based on structural investigations.

Authors:  M Brufani; S Cerrini; W Fedeli; A Vaciago
Journal:  J Mol Biol       Date:  1974-08-15       Impact factor: 5.469

3.  Polymorphism-structure relationships of rifamexil, an antibiotic rifamycin derivative.

Authors:  A Bacchi; G Mori; G Pelizzi; G Pelosi; M Nebuloni; G B Panzone
Journal:  Mol Pharmacol       Date:  1995-03       Impact factor: 4.436

4.  Correlation of structure and activity in ansamycins: molecular structure of cyclized rifamycin SV.

Authors:  S K Arora; P Main
Journal:  J Antibiot (Tokyo)       Date:  1984-02       Impact factor: 2.649

5.  X-ray crystal structure of 4-deoxy-3'-bromopyrido[1',2'-1,2]imidazo[5,4-c]rifamycin S.

Authors:  M Brufani; L Cellai; S Cerrini; W Fedeli; E Marchi; A Segre; A Vaciago
Journal:  J Antibiot (Tokyo)       Date:  1984-12       Impact factor: 2.649

6.  Structure-activity relationships in the ansamycins: the crystal structure of tolypomycinone.

Authors:  M Brufani; L Cellai; S Cerrini; W Fedeli; A Vaciago
Journal:  Mol Pharmacol       Date:  1978-07       Impact factor: 4.436

7.  Structure-activity relationships in the ansamycins. Molecular structure and activity of 3-carbomethoxy rifamycin S.

Authors:  M Brufani; L Cellai; S Cerrini; W Fedeli; A Segre; A Vaciago
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

8.  Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV.

Authors:  S K Arora
Journal:  Mol Pharmacol       Date:  1983-01       Impact factor: 4.436

9.  Correlation of structure and activity in ansamycins: structure, conformation, and interactions of antibiotic rifamycin S.

Authors:  S K Arora
Journal:  J Med Chem       Date:  1985-08       Impact factor: 7.446

10.  Comprehensive study on structure-activity relationships of rifamycins: discussion of molecular and crystal structure and spectroscopic and thermochemical properties of rifamycin O.

Authors:  A Bacchi; G Pelizzi; M Nebuloni; P Ferrari
Journal:  J Med Chem       Date:  1998-06-18       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.